The cost of treatment of anemia by rhEPO was estimated at USD 24,128.03 for the Hb level 9–10 g/dL and USD 28,022.33 for the Hb level 11–12 g/dL per quality-adjusted life-year [21]. The gene discussed is GSTM1; the disease is anemia (phenotype).